Multiply Labs develops robotic systems that manufacture individualized drugs at industrial scale.

Multiply Labs’ robotic systems leverage the latest advancements in autonomous technology – from collaborative robots to cloud-controlled fleets – to enable the production of individualized drugs at industrial scale.
-
Industry
-
Milestones
- Lux investment: 2021
-
Founders
- Fred Parietti, PhD
- Alice Melocchi, PhD
LUX Partners
-
Latest Tweets
- We are excited to announce that we have added @thermofisher and @CRiverLabs to our Robotic Manufacturing Consortium… https://t.co/SbRrtSgMMx
- The @multiplylabs team has lots of surprises in store! In this fantastic article on the @techreview, we show some o… https://t.co/XZJp3g7HKo
- We are happy to be featured with our partner @Cytiva in a comprehensive @FiercePharma review of the pioneering robo… https://t.co/20jTnkWYmV